Early treatment switch in cardiac AL amyloidosis: a case of suboptimal response to first-line Dara-CyBorD regimen followed by switch to teclistamab

Scritto il 11/03/2026
da Yang Liu

No abstract

Leuk Lymphoma. 2026 Mar 11:1-3. doi: 10.1080/10428194.2026.2637859. Online ahead of print.

NO ABSTRACT

PMID:41811838 | DOI:10.1080/10428194.2026.2637859